How big is the global malignant mesothelioma market in 2026?

The global malignant mesothelioma market is projected to be valued at US$ 661.4 Mn in 2026.

What drives the global malignant mesothelioma market?

Rising asbestos exposure, advanced therapies, early diagnosis, immunotherapy adoption, and increasing oncology research drive growth.

What is the growth rate for the global malignant mesothelioma market?

The global malignant mesothelioma market is poised to witness a CAGR of 8.1% between 2026 and 2033.

What are the key market opportunities?

Novel immunotherapies, combination regimens, biomarker-driven personalized treatments, emerging markets, and minimally invasive diagnostics present key opportunities.

Who are the key players in the global malignant mesothelioma market?

AstraZeneca Plc, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer Inc.

Table of Content - Malignant Mesothelioma Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Executive Summary
1. Global Malignant Mesothelioma Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 – 2033, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors – Relevance and Impact
Value Added Insights
1. Regulatory Landscape
2. Product Adoption Analysis
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Global Malignant Mesothelioma Market Outlook:
1. Key Highlights
  1. Market Size (US$ Mn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2020-2025
  2. Market Size (US$ Mn) Analysis and Forecast, 2026–2033
3. Global Malignant Mesothelioma Market Outlook: Drug Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Drug Type, 2020 – 2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
    1. Pemetrexed
    2. Cisplatin
    3. Carboplatin
    4. Gemcitabine
    5. Vinorelbine
    6. Others
  4. Market Attractiveness Analysis: Drug Type
4. Global Malignant Mesothelioma Market Outlook: Route of Administration
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2020 – 2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
    1. Diagnostics
    2. Drug Discovery and Development
    3. Oncology
    4. Immunology
    5. Others
  4. Market Attractiveness Analysis: Route of Administration
5. Global Malignant Mesothelioma Market Outlook: Distribution Channel
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2020 – 2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
    1. Biopharmaceutical & Biotechnology Companies
    2. Academic Institutes & Research Laboratories
    3. Hospitals
    4. Contract Research Organizations
    5. Others
  4. Market Attractiveness Analysis: Distribution Channel
Global Malignant Mesothelioma Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Region, 2020 – 2025
3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026 – 2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Malignant Mesothelioma Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Type
  3. By Route of Administration
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
  1. U.S.
  2. Canada
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
  1. Pemetrexed
  2. Cisplatin
  3. Carboplatin
  4. Gemcitabine
  5. Vinorelbine
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
  1. Oral
  2. Parenteral
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Oncology Centers
7. Market Attractiveness Analysis
Europe Malignant Mesothelioma Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Type
  3. By Route of Administration
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
  1. Pemetrexed
  2. Cisplatin
  3. Carboplatin
  4. Gemcitabine
  5. Vinorelbine
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
  1. Oral
  2. Parenteral
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Oncology Centers
7. Market Attractiveness Analysis
East Asia Malignant Mesothelioma Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Type
  3. By Route of Administration
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
  1. Pemetrexed
  2. Cisplatin
  3. Carboplatin
  4. Gemcitabine
  5. Vinorelbine
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
  1. Oral
  2. Parenteral
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Oncology Centers
7. Market Attractiveness Analysis
South Asia & Oceania Malignant Mesothelioma Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Type
  3. By Route of Administration
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
  1. Pemetrexed
  2. Cisplatin
  3. Carboplatin
  4. Gemcitabine
  5. Vinorelbine
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
  1. Oral
  2. Parenteral
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Oncology Centers
7. Market Attractiveness Analysis
Latin America Malignant Mesothelioma Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Type
  3. By Route of Administration
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
  1. Pemetrexed
  2. Cisplatin
  3. Carboplatin
  4. Gemcitabine
  5. Vinorelbine
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
  1. Oral
  2. Parenteral
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Oncology Centers
7. Market Attractiveness Analysis
Middle East & Africa Malignant Mesothelioma Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Type
  3. By Route of Administration
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
  1. Pemetrexed
  2. Cisplatin
  3. Carboplatin
  4. Gemcitabine
  5. Vinorelbine
  6. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
  1. Oral
  2. Parenteral
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Oncology Centers
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
  1. AstraZeneca Plc.
    1. Overview
    2. Segments and Products
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Bristol-Myers Squibb Company
  3. F. Hoffmann-La Roche Ltd.
  4. Merck & Co., Inc.
  5. Novartis AG
  6. Pfizer Inc.
  7. Sanofi
  8. Eli Lilly and Company
  9. Teva Pharmaceuticals
  10. Boehringer Ingelheim GmbH
  11. Mylan N.V.
  12. Fresenius Kabi AG
  13. Sun Pharmaceuticals Industries Ltd
  14. Corden Pharma International GmbH
  15. Concordia International Corp
  16. Kyowa Hakko Kirin Co Ltd.
  17. Polaris Pharmaceuticals, Inc.
  18. MolMed SpA
  19. Ono Pharmaceutical Co. Ltd
  20. Nichi-Iko Pharmaceutical Co., Ltd
  21. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Malignant Mesothelioma Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Malignant Mesothelioma Market by Drug Type (Pemetrexed, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Others), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Oncology Centers), and Regional Analysis from 2026 to 2033

Quick Links

Our Partners

Secure Payments Through